26 Jun 2023 --- The US FDA has approved Pfizer’s Litfulo (ritlecitinib), a once-daily oral treatment for severe alopecia areata in adults and adolescents. It is also the first treatment the agency authorizes for people over 12 and will be available in the coming weeks.
